Literature DB >> 7829010

Depressed T cell reactivity to recall antigens in Crohn's disease before and after surgical resection.

G D'Haens1, M Hiele, P Rutgeerts, K Geboes, J L Ceuppens.   

Abstract

Earlier studies regarding possible primary immune disturbances participating in the pathogenesis of Crohn's disease yielded conflicting results. Peripheral blood lymphocyte subsets and lymphocyte proliferative responses to five soluble recall antigens and to the polyclonal stimulator phythaemagglutinin were therefore measured in 17 patients with active Crohn's disease, before and six months after surgical resection of the inflamed intestine and in 16 healthy controls. Lymphocyte proliferation in response to all five recall antigens was significantly lower in patients than in controls. No significant differences with controls were detected after surgery. Addition of indomethacin to phythaemagglutinin stimulated lymphocyte cultures had a stronger proliferation enhancing effect in patients than in controls, resulting in comparable proliferative responses in both groups. When both indomethacin and prostaglandin E2 were added, inhibition of reactivity by prostaglandin E2 was stronger in patients' cultures. This suggests a higher sensitivity to inflammatory prostaglandins in Crohn's disease. The degree of lymphocyte stimulation by antigens correlated positively with the percentage of circulating memory T cells (CD 45 RA-). The percentage of activated (HLA-DR+) CD8 cells was higher in patients than in controls. The CD4/CD8 ratio, which was not significantly different between patients and controls, correlated significantly with disease activity and characteristics, even in the postoperative phase. These findings suggest that immune abnormalities in Crohn's disease fluctuate with and are probably secondary to inflammatory activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7829010      PMCID: PMC1375261          DOI: 10.1136/gut.35.12.1728

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  32 in total

Review 1.  Immunological aspects of inflammatory bowel disease.

Authors:  K Deusch; K Reich
Journal:  Endoscopy       Date:  1992-08       Impact factor: 10.093

2.  Assay of prostaglandin-like substances in faeces and their measurement in ulcerative colitis.

Authors:  S R Gould
Journal:  Prostaglandins       Date:  1976-03

3.  No evidence for decreased lymphocyte reactivity in Crohn's disease.

Authors:  A G Bird; S Britton
Journal:  Gastroenterology       Date:  1974-11       Impact factor: 22.682

4.  A study of Crohn's syndrome using tissue extracts and the Kveim and Mantoux tests.

Authors:  W J Williams
Journal:  Gut       Date:  1965-10       Impact factor: 23.059

5.  Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood.

Authors:  I O Auer; E Ziemer; H Sommer
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

6.  Increased prostaglandin production in ulcerative colitis.

Authors:  S R Gould; A R Brash; M E Conolly
Journal:  Lancet       Date:  1977-07-09       Impact factor: 79.321

Review 7.  Prostaglandins as mediators of inflammation.

Authors:  J R Vane
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1976

8.  Immune status in Crohn's disease. 4. In vitro antibody dependent cell mediated cytotoxicity in peripheral blood.

Authors:  I O Auer; E Ziemer
Journal:  Klin Wochenschr       Date:  1980-08-01

9.  The immune competence of patients with inflammatory bowel disease.

Authors:  P M Bolton; S L James; R G Newcombe; R H Whitehead; L E Hughes
Journal:  Gut       Date:  1974-03       Impact factor: 23.059

10.  Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization.

Authors:  D T Yu; R J Winchester; S M Fu; A Gibofsky; H S Ko; H G Kunkel
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.